 |
PDBsum entry 3csg
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
De novo protein, sugar binding protein
|
PDB id
|
|
|
|
3csg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
381:407-418
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
A dominant conformational role for amino acid diversity in minimalist protein-protein interfaces.
|
|
R.N.Gilbreth,
K.Esaki,
A.Koide,
S.S.Sidhu,
S.Koide.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Recent studies have shown that highly simplified interaction surfaces consisting
of combinations of just two amino acids, Tyr and Ser, exhibit high affinity and
specificity. The high functional levels of such minimalist interfaces might thus
indicate small contributions of greater amino acid diversity seen in natural
interfaces. Toward addressing this issue, we have produced a pair of binding
proteins built on the fibronectin type III scaffold, termed "monobodies." One
monobody contains the Tyr/Ser binary-code interface (termed YS) and the other
contains an expanded amino acid diversity interface (YSX), but both bind to an
identical target, maltose-binding protein. The YSX monobody bound with higher
affinity, a slower off rate and a more favorable enthalpic contribution than the
YS monobody. High-resolution X-ray crystal structures revealed that both
proteins bound to an essentially identical epitope, providing a unique
opportunity to directly investigate the role of amino acid diversity in a
protein interaction interface. Surprisingly, Tyr still dominates the YSX
paratope and the additional amino acid types are primarily used to
conformationally optimize contacts made by tyrosines. Scanning mutagenesis
showed that while all contacting Tyr side chains are essential in the YS
monobody, the YSX interface was more tolerant to mutations. These results
suggest that the conformational, not chemical, diversity of additional types of
amino acids provided higher functionality and evolutionary robustness,
supporting the dominant role of Tyr and the importance of conformational
diversity in forming protein interaction interfaces.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. The FNfn10 scaffold and loop sequences of MBP-binding
monobodies. (a) A schematic of the FNIII scaffold. The seven
β-strands are labeled A–G and three loops used for interface
design (BC, DE and FG) are labeled. (b) The amino acid sequences
of the loop regions of YS-only monobody YS1 and monobodies from
the YSX library. For the latter group, the number of times each
sequence was recovered is indicated in parentheses. The
dissociation constant for MBP as measured by yeast display is
also given. Unmutated residues originating from the mutagenesis
template are colored gray.
|
 |
Figure 4.
Fig. 4. The paratope structures of the YS1 and YSX1
monobodies. (a) The surface area buried at the interface of
individual residues in the BC and FG loops of YS1 and YSX1. (b)
The interface buried surface area contributed by each amino type
to the YS1 and YSX1 paratopes. (c and d) Structural details of
the YS1 and YSX1 interfaces. The left panels show an overall
view of the arrangement of major interface contacts and the
right panels show close-up views of these interactions. In these
illustrations, MBP is shown as a gray surface/sticks and
contacting monobody paratope residues are shown as sticks. The
carbon atoms of the FG loop residues are colored green, and
those of the BC loop residues cyan. Putative hydrogen bonds are
indicated by dashed lines.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Elsevier:
J Mol Biol
(2008,
381,
407-418)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Lipovsek
(2011).
Adnectins: engineered target-binding protein therapeutics.
|
| |
Protein Eng Des Sel,
24,
3-9.
|
 |
|
|
|
|
 |
G.Schreiber,
and
A.E.Keating
(2011).
Protein binding specificity versus promiscuity.
|
| |
Curr Opin Struct Biol,
21,
50-61.
|
 |
|
|
|
|
 |
R.N.Gilbreth,
K.Truong,
I.Madu,
A.Koide,
J.B.Wojcik,
N.S.Li,
J.A.Piccirilli,
Y.Chen,
and
S.Koide
(2011).
Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
|
| |
Proc Natl Acad Sci U S A,
108,
7751-7756.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.Hackel,
and
K.D.Wittrup
(2010).
The full amino acid repertoire is superior to serine/tyrosine for selection of high affinity immunoglobulin G binders from the fibronectin scaffold.
|
| |
Protein Eng Des Sel,
23,
211-219.
|
 |
|
|
|
|
 |
C.W.Diehnelt,
M.Shah,
N.Gupta,
P.E.Belcher,
M.P.Greving,
P.Stafford,
and
S.A.Johnston
(2010).
Discovery of high-affinity protein binding ligands--backwards.
|
| |
PLoS One,
5,
e10728.
|
 |
|
|
|
|
 |
J.Wojcik,
O.Hantschel,
F.Grebien,
I.Kaupe,
K.L.Bennett,
J.Barkinge,
R.B.Jones,
A.Koide,
G.Superti-Furga,
and
S.Koide
(2010).
A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain.
|
| |
Nat Struct Mol Biol,
17,
519-527.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.G.Brown,
and
T.Palzkill
(2010).
Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.
|
| |
Protein Eng Des Sel,
23,
469-478.
|
 |
|
|
|
|
 |
R.J.Falconer,
A.Penkova,
I.Jelesarov,
and
B.M.Collins
(2010).
Survey of the year 2008: applications of isothermal titration calorimetry.
|
| |
J Mol Recognit,
23,
395-413.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit,
23,
1.
|
 |
|
|
|
|
 |
Z.S.Derewenda
(2010).
Application of protein engineering to enhance crystallizability and improve crystal properties.
|
| |
Acta Crystallogr D Biol Crystallogr,
66,
604-615.
|
 |
|
|
|
|
 |
A.Koide,
J.Wojcik,
R.N.Gilbreth,
A.Reichel,
J.Piehler,
and
S.Koide
(2009).
Accelerating phage-display library selection by reversible and site-specific biotinylation.
|
| |
Protein Eng Des Sel,
22,
685-690.
|
 |
|
|
|
|
 |
J.Huang,
K.Makabe,
M.Biancalana,
A.Koide,
and
S.Koide
(2009).
Structural basis for exquisite specificity of affinity clamps, synthetic binding proteins generated through directed domain-interface evolution.
|
| |
J Mol Biol,
392,
1221-1231.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Bloom,
and
V.Calabro
(2009).
FN3: a new protein scaffold reaches the clinic.
|
| |
Drug Discov Today,
14,
949-955.
|
 |
|
|
|
|
 |
M.Gebauer,
and
A.Skerra
(2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
|
| |
Curr Opin Chem Biol,
13,
245-255.
|
 |
|
|
|
|
 |
R.H.Kimura,
A.M.Levin,
F.V.Cochran,
and
J.R.Cochran
(2009).
Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.
|
| |
Proteins,
77,
359-369.
|
 |
|
|
|
|
 |
S.Koide,
and
S.S.Sidhu
(2009).
The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins.
|
| |
ACS Chem Biol,
4,
325-334.
|
 |
|
|
|
|
 |
S.Koide
(2009).
Engineering of recombinant crystallization chaperones.
|
| |
Curr Opin Struct Biol,
19,
449-457.
|
 |
|
|
|
|
 |
T.V.Pavoor,
Y.K.Cho,
and
E.V.Shusta
(2009).
Development of GFP-based biosensors possessing the binding properties of antibodies.
|
| |
Proc Natl Acad Sci U S A,
106,
11895-11900.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |